Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity
- PMID: 35334353
- PMCID: PMC10575344
- DOI: 10.1016/j.ejpn.2022.03.004
Verbal learning and memory in youth with neurofibromatosis type 1 and plexiform neurofibromas: Relationships with disease severity
Abstract
Aim: To provide a comprehensive characterization of verbal learning and memory (VLM) abilities in youth with neurofibromatosis type 1 (NF1) and plexiform neurofibromas (PNs) and to evaluate disease severity as a predictor of VLM functioning over time.
Method: As part of a longitudinal natural history study, youth with NF1 and PNs were administered repeat neuropsychological assessments, including measures of VLM and ratings of NF1 disease severity completed by a medical professional. This sub-study analyzed data from 89 patients (M age baseline = 13.1, SD = 4.3 years, range 6-24 years) who had completed tests of VLM abilities and verbal attention at either baseline and/or 36 months.
Results: VLM scores across the sample fell predominantly within the average range of functioning at both time points. However, relative to peers with mild NF1 disease severity, youth with moderate/severe NF1 disease showed lower functioning across multiple VLM domains at 36 months, even after controlling for the effects of verbal attention.
Interpretation: Exclusive use of overall domain scores does not fully characterize VLM functioning in youth with NF1 and PNs. Additionally, children and adolescents with more severe NF1 disease should be monitored more closely for verbal memory challenges and targeted for interventions.
Keywords: Neurofibromatosis type 1 (NF1); Plexiform neurofibroma (PN); Verbal learning and memory.
© 2022 Published by Elsevier Ltd on behalf of European Paediatric Neurology Society.
References
-
- North K, Neurofibromatosis type 1, Am. J. Med. Genet. 97 (2) (2000) 119–127. - PubMed
-
- Neurofibromatosis Stumpf D.. Conference Statement, National Institute of Health development conference. Arch Neurol [Internet]. 1988. [cited 2021 Jan 24];45: 575–8. Available from: http://ci.nii.ac.jp/naid/10024296720/en/. - PubMed
-
- Lehtonen A, Howie E, Trump D, Huson SM, Behaviour in children with neurofibromatosis type 1: cognition, executive function, attention, emotion, and social competence, Dev. Med. Child Neurol. 55 (2) (2013) 111–125. - PubMed
-
- Martin S, Wolters P, Baldwin A, Gillespie A, Dombi E, Walker K, et al., Social–emotional functioning of children and adolescents with Neurofibromatosis Type 1 and plexiform neurofibromas: relationships with cognitive, disease, and environmental variables, J. Pediatr. Psychol. 37 (7) (2012) 713–724. - PMC - PubMed
-
- Nguyen R, Kluwe L, Fuensterer C, Kentsch M, Friedrich RE, Mautner V-F, Plexiform neurofibromas in children with neurofibromatosis type 1: frequency and associated clinical deficits, J. Pediatr. 159 (4) (2011) 652–655. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous